ATLASRoivant Sciences (ROIV) earnings date: Nov 9, 2026
Roivant Sciences (ROIV) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, before the open. Analysts expect EPS of -$0.52.
Source: company filings and exchange data · Updated Nov 2, 2026
Roivant Sciences reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Roivant Sciences. You can switch it off at any time.
Alert me before ROIV reportsFree to start. Creating an account takes under a minute.
ROIV earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.52 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +10.5% |
| Average move around a report | ±10.2% (last 5) |
| Sector | Healthcare · Biotechnology |
Roivant Sciences earnings history: last 5 reports
Roivant Sciences last reported on Aug 6, 2026: EPS of -$0.34 against an estimate of -$0.36 (+5.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.36 | -$0.34 | +5.6% | Beat | +5.0% |
| May 20, 2026 | -$0.35 | -$0.32 | +8.6% | Beat | +9.5% |
| Apr 10, 2026 | -$0.16 | -$0.14 | +12.5% | Beat | +1.7% |
| Feb 17, 2026 | $3.94 | $4.07 | +3.3% | Beat | +3.9% |
| Feb 6, 2026 | -$0.31 | -$0.24 | +22.6% | Beat | +30.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on ROIV before the report
| Last price | $36.91 (-1.6%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 49% |
| Likely 1-month range (50%) | $34.07 – $39.78 |
| Normal 1-day range (±1σ) | ±2.6% |
These figures come from the same calibrated model and valuation as the Roivant Sciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for ROIV
See the fair value, the probability range and the earnings history of Roivant Sciences on its ATLAS page.
Roivant Sciences (ROIV) stock analysisPlans from €3.99 a month.
Roivant Sciences earnings: frequently asked questions
When does Roivant Sciences (ROIV) report earnings?
Roivant Sciences is scheduled to report on Monday, November 9, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ROIV?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.52 per share (USD). Estimates can change before the report.
How often does ROIV beat earnings estimates?
Of its last 5 reports with a recorded result, Roivant Sciences beat the EPS estimate 5 times; the average surprise was +10.5%. Past results do not predict the next one.
How much does ROIV move around earnings?
Over its last 5 reports the stock moved an average of 10.2% (absolute, from the close before the report day to the close after it), and finished higher 5 of 5 times.
Did Roivant Sciences beat earnings estimates last quarter?
Roivant Sciences last reported on Aug 6, 2026: EPS of -$0.34 against an estimate of -$0.36 (+5.6% surprise), a beat.
How much does ROIV usually move in a day?
On a normal trading day the ATLAS model puts ROIV’s one-day range at about ±2.6%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer